Leão, R.P.; Cruz, J.V.; da Costa, G.V.; Cruz, J.N.; Ferreira, E.F.B.; Silva, R.C.; de Lima, L.R.; Borges, R.S.; dos Santos, G.B.; Santos, C.B.R.
Identification of New Rofecoxib-Based Cyclooxygenase-2 Inhibitors: A Bioinformatics Approach. Pharmaceuticals 2020, 13, 209.
https://doi.org/10.3390/ph13090209
AMA Style
Leão RP, Cruz JV, da Costa GV, Cruz JN, Ferreira EFB, Silva RC, de Lima LR, Borges RS, dos Santos GB, Santos CBR.
Identification of New Rofecoxib-Based Cyclooxygenase-2 Inhibitors: A Bioinformatics Approach. Pharmaceuticals. 2020; 13(9):209.
https://doi.org/10.3390/ph13090209
Chicago/Turabian Style
Leão, Rozires P., Josiane V. Cruz, Glauber V. da Costa, Jorddy N. Cruz, Elenilze F. B. Ferreira, Raí C. Silva, Lúcio R. de Lima, Rosivaldo S. Borges, Gabriela B. dos Santos, and Cleydson B. R. Santos.
2020. "Identification of New Rofecoxib-Based Cyclooxygenase-2 Inhibitors: A Bioinformatics Approach" Pharmaceuticals 13, no. 9: 209.
https://doi.org/10.3390/ph13090209
APA Style
Leão, R. P., Cruz, J. V., da Costa, G. V., Cruz, J. N., Ferreira, E. F. B., Silva, R. C., de Lima, L. R., Borges, R. S., dos Santos, G. B., & Santos, C. B. R.
(2020). Identification of New Rofecoxib-Based Cyclooxygenase-2 Inhibitors: A Bioinformatics Approach. Pharmaceuticals, 13(9), 209.
https://doi.org/10.3390/ph13090209
